Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro

Detalhes bibliográficos
Autor(a) principal: Morais, Ines
Data de Publicação: 2022
Outros Autores: Medeiros, M.M., Carvalho, Maria, Morello Bullon, Judit, M. Teixeira, Sara, Maciel, Suelma, Nhantumbo, Janice, Balau, Ana, T.G. Rosa, Margarida, Nogueira, F, A. Rodrigues, João, Carvalho, Filomena A., Antunes, Alexandra M M, Arez, Ana Paula
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/140652
Resumo: Mechanisms of malaria parasite interaction with its host red blood cell may provide potential targets for new antimalarial approaches. Pyruvate kinase deficiency has been associated with resistance to malaria in both experimental models and population studies. Two of the major pyruvate kinase deficient-cell disorders are the decrease in ATP and the increase in 2,3-biphosphoglycerate (2,3-BPG) concentration. High levels of this metabolite, only present in mammalian red blood cell, has an inhibitory effect on glycolysis and we hypothesized that its accumulation may also be harmful to the parasite and be involved in the mechanism of protection provided by that enzymopathy. We examined the effect of a synthetic form, 2,3-DPG, on the Plasmodium falciparum intraerythrocytic developmental cycle in vitro. Results showed an impairment of parasite growth with a direct effect on parasite maturation as significant lower progeny emerged from parasites that were submitted to 2,3-DPG. Further, adding the compound to the culture medium did not result in any effect on the host cell, but instead the metabolic profile of an infected cell became closer to that of a non-infected cell.
id RCAP_75efffbe35274599e047d6abafcd056f
oai_identifier_str oai:run.unl.pt:10362/140652
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In VitroMalariaHost-parasite interactionsRed blood cell2,3-DPGGlycolysisPyruvate kinase deficiency2,3-BPGBiochemistry, Genetics and Molecular Biology (miscellaneous)Applied Microbiology and BiotechnologyParasitologyBiochemistry, medicalEpidemiologyPharmacology, Toxicology and Pharmaceutics (miscellaneous)SDG 1 - No PovertySDG 3 - Good Health and Well-beingSDG 9 - Industry, Innovation, and InfrastructureSDG 10 - Reduced InequalitiesMechanisms of malaria parasite interaction with its host red blood cell may provide potential targets for new antimalarial approaches. Pyruvate kinase deficiency has been associated with resistance to malaria in both experimental models and population studies. Two of the major pyruvate kinase deficient-cell disorders are the decrease in ATP and the increase in 2,3-biphosphoglycerate (2,3-BPG) concentration. High levels of this metabolite, only present in mammalian red blood cell, has an inhibitory effect on glycolysis and we hypothesized that its accumulation may also be harmful to the parasite and be involved in the mechanism of protection provided by that enzymopathy. We examined the effect of a synthetic form, 2,3-DPG, on the Plasmodium falciparum intraerythrocytic developmental cycle in vitro. Results showed an impairment of parasite growth with a direct effect on parasite maturation as significant lower progeny emerged from parasites that were submitted to 2,3-DPG. Further, adding the compound to the culture medium did not result in any effect on the host cell, but instead the metabolic profile of an infected cell became closer to that of a non-infected cell.Vector borne diseases and pathogens (VBD)Global Health and Tropical Medicine (GHTM)Instituto de Higiene e Medicina Tropical (IHMT)Centro de Estudos de Doenças Crónicas (CEDOC)NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNMorais, InesMedeiros, M.M.Carvalho, MariaMorello Bullon, JuditM. Teixeira, SaraMaciel, SuelmaNhantumbo, JaniceBalau, AnaT.G. Rosa, MargaridaNogueira, FA. Rodrigues, JoãoCarvalho, Filomena A.Antunes, Alexandra M MArez, Ana Paula2022-06-23T22:24:09Z2022-03-152022-03-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article14application/pdfhttp://hdl.handle.net/10362/140652eng2235-2988PURE: 42494547https://doi.org/10.3389/fcimb.2022.840968info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:17:50Zoai:run.unl.pt:10362/140652Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:49:45.009309Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
title Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
spellingShingle Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
Morais, Ines
Malaria
Host-parasite interactions
Red blood cell
2,3-DPG
Glycolysis
Pyruvate kinase deficiency
2,3-BPG
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Applied Microbiology and Biotechnology
Parasitology
Biochemistry, medical
Epidemiology
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
SDG 1 - No Poverty
SDG 3 - Good Health and Well-being
SDG 9 - Industry, Innovation, and Infrastructure
SDG 10 - Reduced Inequalities
title_short Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
title_full Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
title_fullStr Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
title_full_unstemmed Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
title_sort Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
author Morais, Ines
author_facet Morais, Ines
Medeiros, M.M.
Carvalho, Maria
Morello Bullon, Judit
M. Teixeira, Sara
Maciel, Suelma
Nhantumbo, Janice
Balau, Ana
T.G. Rosa, Margarida
Nogueira, F
A. Rodrigues, João
Carvalho, Filomena A.
Antunes, Alexandra M M
Arez, Ana Paula
author_role author
author2 Medeiros, M.M.
Carvalho, Maria
Morello Bullon, Judit
M. Teixeira, Sara
Maciel, Suelma
Nhantumbo, Janice
Balau, Ana
T.G. Rosa, Margarida
Nogueira, F
A. Rodrigues, João
Carvalho, Filomena A.
Antunes, Alexandra M M
Arez, Ana Paula
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Vector borne diseases and pathogens (VBD)
Global Health and Tropical Medicine (GHTM)
Instituto de Higiene e Medicina Tropical (IHMT)
Centro de Estudos de Doenças Crónicas (CEDOC)
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Morais, Ines
Medeiros, M.M.
Carvalho, Maria
Morello Bullon, Judit
M. Teixeira, Sara
Maciel, Suelma
Nhantumbo, Janice
Balau, Ana
T.G. Rosa, Margarida
Nogueira, F
A. Rodrigues, João
Carvalho, Filomena A.
Antunes, Alexandra M M
Arez, Ana Paula
dc.subject.por.fl_str_mv Malaria
Host-parasite interactions
Red blood cell
2,3-DPG
Glycolysis
Pyruvate kinase deficiency
2,3-BPG
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Applied Microbiology and Biotechnology
Parasitology
Biochemistry, medical
Epidemiology
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
SDG 1 - No Poverty
SDG 3 - Good Health and Well-being
SDG 9 - Industry, Innovation, and Infrastructure
SDG 10 - Reduced Inequalities
topic Malaria
Host-parasite interactions
Red blood cell
2,3-DPG
Glycolysis
Pyruvate kinase deficiency
2,3-BPG
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Applied Microbiology and Biotechnology
Parasitology
Biochemistry, medical
Epidemiology
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
SDG 1 - No Poverty
SDG 3 - Good Health and Well-being
SDG 9 - Industry, Innovation, and Infrastructure
SDG 10 - Reduced Inequalities
description Mechanisms of malaria parasite interaction with its host red blood cell may provide potential targets for new antimalarial approaches. Pyruvate kinase deficiency has been associated with resistance to malaria in both experimental models and population studies. Two of the major pyruvate kinase deficient-cell disorders are the decrease in ATP and the increase in 2,3-biphosphoglycerate (2,3-BPG) concentration. High levels of this metabolite, only present in mammalian red blood cell, has an inhibitory effect on glycolysis and we hypothesized that its accumulation may also be harmful to the parasite and be involved in the mechanism of protection provided by that enzymopathy. We examined the effect of a synthetic form, 2,3-DPG, on the Plasmodium falciparum intraerythrocytic developmental cycle in vitro. Results showed an impairment of parasite growth with a direct effect on parasite maturation as significant lower progeny emerged from parasites that were submitted to 2,3-DPG. Further, adding the compound to the culture medium did not result in any effect on the host cell, but instead the metabolic profile of an infected cell became closer to that of a non-infected cell.
publishDate 2022
dc.date.none.fl_str_mv 2022-06-23T22:24:09Z
2022-03-15
2022-03-15T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/140652
url http://hdl.handle.net/10362/140652
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2235-2988
PURE: 42494547
https://doi.org/10.3389/fcimb.2022.840968
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 14
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138095765913600